BioPharma

30 March, 2026 | Monday | News

Lonza Expands Bioprocessing Capabilities With Media Development Lab In Singapore

New media development services designed to optimize cell culture media development and identify robust, scalable media formulations driving cell culture performance and reliability The offering is ...

Lab

01 April, 2026 | Wednesday | News

Roche Secures FDA Clearance For Cobas c 703 And Cobas ISE Neo Analytical Units

The cobas® c 703 and cobas® ISE neo analytical units deliver higher testing capacity and increased automation, helping to improve laboratory workflows and advance patient care. High-throughput effici...

BioTech

20 March, 2026 | Friday | News

Excalipoint Therapeutics Secures 68.7 Million Dollar Seed Financing To Advance Next Generation T Cell Engager Platforms

Funding to advance proprietary T-cell engager platforms and pipeline of highly differentiated T-cell engager therapies targeting solid tumors and autoimmune diseases Financing co-led by multiple top-tier f...

Contract Services

31 March, 2026 | Tuesday | News

Thermo Fisher Scientific Expands Access To Structural Biology With Glacios 3 Cryo TEM

Equipped with the READY System to make structural biology research accessible to more labs Thermo Fisher Scientific, the world leader in serving science, introduces a next-generation cryogenic transmission ele...

Consumer Health

31 March, 2026 | Tuesday | News

Aroa Biosurgery Reports Positive Primary Endpoint Achievement In Symphony RCT For Diabetic Foot Ulcers

Aroa Biosurgery Limited announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial achieved its primary endpoint. Symphony is AROA...

Medtech

27 March, 2026 | Friday | News

Infosys To Acquire Optimum Healthcare IT To Strengthen AI Led Healthcare Transformation

Acquisition to unlock AI-powered cloud and digital transformation for healthcare providers  Infosys  a global leader in next-generation digital services and consulting,  announced a definitive a...

Cell & Gene

31 March, 2026 | Tuesday | News

Matricelf And CiRA Foundation Partner To Advance Scalable iPSC Based Neural Tissue Manufacturing

Matricelf Ltd. (TASE: MTLF), a biotechnology company developing a novel autologous engineered neural tissue therapy for patients with spinal cord injury, announced it has entered into a Collaborative Research A...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close